
Sanjeev Srivastava
Sanjeev is an Investor and Senior Capital Markets advisor and currently serves as the Senior Capital Markets Advisor for Exozymes, Inc. (NASDAQ: EXOZ). He has over two decades of experience in Capital Markets, Investment Management, SPACs, strategic CFO, and as a Board Member. He spent the first decade of his career with J.P. Morgan based in New York City. He has a MBA in Finance and Marketing from NYU Stern School of Business and a BS in Chemical Engineering from University of Rochester.
Topic
November 13, 2026 November 13, 2025
How Investment Funds Evaluate Deals
- Hedge funds vs. family offices: Key differences
- Risk-return considerations: Liquidity, control provisions, and exit strategies
- What investors look for in PIPE deals beyond the discount
- Other desirable deal criteria